These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20388078)

  • 1. Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications.
    Di Bona D; Scapagnini G; Candore G; Castiglia L; Colonna-Romano G; Duro G; Nuzzo D; Iemolo F; Lio D; Pellicanò M; Scafidi V; Caruso C; Vasto S
    Curr Pharm Des; 2010; 16(6):684-91. PubMed ID: 20388078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, genes and zinc in Alzheimer's disease.
    Vasto S; Candore G; Listì F; Balistreri CR; Colonna-Romano G; Malavolta M; Lio D; Nuzzo D; Mocchegiani E; Di Bona D; Caruso C
    Brain Res Rev; 2008 Jun; 58(1):96-105. PubMed ID: 18190968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
    Agostinho P; Cunha RA; Oliveira C
    Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal and inflammatory targets for Alzheimer's disease.
    Rogers JT; Lahiri DK
    Curr Drug Targets; 2004 Aug; 5(6):535-51. PubMed ID: 15270200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
    Kwon Y
    Exp Gerontol; 2017 Sep; 95():39-43. PubMed ID: 28528007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease.
    Ozben T; Ozben S
    Clin Biochem; 2019 Oct; 72():87-89. PubMed ID: 30954437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathological cascade of Alzheimer's disease: the role of inflammation and its therapeutic implications.
    Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
    Drugs Today (Barc); 2002 Jun; 38(6):429-43. PubMed ID: 12532179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease.
    Moneim AE
    Curr Alzheimer Res; 2015; 12(4):335-49. PubMed ID: 25817254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
    Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
    Weisman D; Hakimian E; Ho GJ
    Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: a pharmacogenomic approach.
    Candore G; Balistreri CR; Grimaldi MP; Listì F; Vasto S; Chiappelli M; Licastro F; Colonna-Romano G; Lio D; Caruso C
    Mech Ageing Dev; 2007 Jan; 128(1):67-75. PubMed ID: 17116319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines.
    Sharman MJ; Verdile G; Kirubakaran S; Parenti C; Singh A; Watt G; Karl T; Chang D; Li CG; Münch G
    CNS Drugs; 2019 May; 33(5):457-480. PubMed ID: 30900203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
    Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
    Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
    Huang W; Li Z; Zhao L; Zhao W
    Biomed Pharmacother; 2017 Aug; 92():46-57. PubMed ID: 28528185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.